Kim Christopher — SEC Form 4 filings

SEC reporting owner CIK 2040022. 3 Form 4 filings on record with FilingPulse; latest filed 2025-10-17.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-05-15 to 2025-10-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Apimeds Pharmaceuticals US, Inc. (APUS)Chairman and CMO, Director32 legs · 27,500 sh · $50,3592

Form 4 filings — Kim Christopher

FiledFormIssuerReported transactionsSource
2025-10-174Apimeds Pharmaceuticals US, Inc. (APUS)Grant/award (A): 3,000 (derivative) @ $0EDGAR
2025-05-204Apimeds Pharmaceuticals US, Inc. (APUS)Grant/award (A): 250,000 @ $0EDGAR
2025-05-154Apimeds Pharmaceuticals US, Inc. (APUS)Purchase (P): 19,770 @ $1.82 · Purchase (P): 7,730 @ $1.86EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2040022 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →